Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Curis stock
Learn how to easily invest in Curis stock.
Curis Inc is a biotechnology business based in the US. Curis shares (CRIS) are listed on the NASDAQ and all prices are listed in US Dollars. Curis employs 60 staff and has a trailing 12-month revenue of around $10.6 million.
How to buy shares in Curis
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRIS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Curis stock price (NASDAQ: CRIS)Use our graph to track the performance of CRIS stocks over time.
Curis shares at a glance
|Latest market close||$0.70|
|52-week range||$0.68 - $8.20|
|50-day moving average||$0.97|
|200-day moving average||$1.93|
|Wall St. target price||$12.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.56|
Buy Curis shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Curis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Curis price performance over time
|1 week (2022-09-27)||-0.04%|
|1 month (2022-09-02)||-22.68%|
|3 months (2022-07-01)||-25.53%|
|6 months (2022-03-31)||N/A|
|1 year (2021-10-01)||-91.33%|
|2 years (2020-10-02)||-44.00%|
|3 years (2019-10-04)||2.19|
|5 years (2017-10-04)||1.61|
|Revenue TTM||$10.6 million|
|Gross profit TTM||$-24,768,000|
|Return on assets TTM||-21.29%|
|Return on equity TTM||-65%|
|Market capitalisation||$64.3 million|
TTM: trailing 12 months
Curis share dividends
We're not expecting Curis to pay a dividend over the next 12 months.
Have Curis's shares ever split?
Curis's shares were split on a 1:5 basis on 29 May 2018. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Curis shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Curis shares which in turn could have impacted Curis's share price.
Curis share price volatility
Over the last 12 months, Curis's shares have ranged in value from as little as $0.68 up to $8.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Curis's is 2.6536. This would suggest that Curis's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Curis, Inc. , a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc.
Curis in the news
Curis Announces Date for the 1st Symposium on IRAK4 in Cancer
Curis Announces Date for the 2nd Annual VISTA Symposium
Curis to Present at Upcoming Healthcare Conferences in September
Frequently asked questionsWhat percentage of Curis is owned by insiders or institutions?
Currently 6.234% of Curis shares are held by insiders and 48.55% by institutions. How many people work for Curis?
Latest data suggests 60 work at Curis. When does the fiscal year end for Curis?
Curis's fiscal year ends in December. Where is Curis based?
Curis's address is: Building C, Lexington, MA, United States, 02421 What is Curis's ISIN number?
Curis's international securities identification number is: US2312692005 What is Curis's CUSIP number?
Curis's Committee on Uniform Securities Identification Procedures number is: 231269101
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert